Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86671 refers to a laboratory test that is specifically designed to measure antibodies against fungi that are not classified elsewhere. This test is crucial for diagnosing certain conditions related to fungal infections and can provide valuable information in the context of various clinical scenarios. The procedure involves obtaining a blood sample through a process known as venipuncture, which is a standard method for collecting blood for laboratory analysis. The test primarily focuses on detecting specific antibodies, such as IgG and IgA, against the fungus Saccharomyces cerevisiae, utilizing a semi-quantitative enzyme-linked immunosorbent assay (ELISA) technique. This particular test is significant in differentiating between ulcerative colitis and Crohn's disease, especially in patients who present with symptoms indicative of inflammatory bowel disease. Additionally, CPT® Code 86671 encompasses the testing of serum for antibodies against other fungi, including Trichophyton rubrum, Stachybotrys chartarum/atra, and Sporothrix, employing various quantitative immunoassay methods. The results of this test can aid healthcare professionals in making informed decisions regarding diagnosis and treatment options for patients with suspected fungal infections or related conditions.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 86671 is indicated for use in specific clinical scenarios where the presence of fungal antibodies needs to be assessed. The following conditions and symptoms may warrant the use of this test:
The procedure for CPT® Code 86671 involves several key steps that ensure accurate measurement of fungal antibodies in the serum. The following outlines the procedural steps:
After the procedure associated with CPT® Code 86671, patients may experience minimal discomfort at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test; however, patients should be advised to monitor the site for any unusual symptoms, such as excessive bleeding or signs of infection. The results of the test will be communicated to the patient by their healthcare provider, who will discuss the implications of the findings and any necessary follow-up actions or treatments based on the results.
| Short Descr | FUNGUS NES ANTIBODY | Medium Descr | ANTIBODY FUNGUS NOT ELSEWHERE SPECIFIED | Long Descr | Antibody; fungus, not elsewhere specified | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 3 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 76 | Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | 77 | Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | GA | Waiver of liability statement issued as required by payer policy, individual case | PD | Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days | Q4 | Service for ordering/referring physician qualifies as a service exemption | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Short Descriptor changed. |
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.